Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda C Foks

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Plos One|November 8, 2012
Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout miceBart Lammers, Ying Zhao, Amanda C Foks, et al.
Journal of Immunological Methods|August 27, 2025
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug developmentHendrika W Grievink, Coen Breedveld, John Öhd, et al.
European Journal of Pharmacology|November 11, 2024
Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr<sup>-/-</sup> miceEsmeralda Hemme, Marie A C Depuydt, Peter J van Santbrink, et al.
Plos One|December 31, 2013
Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion developmentAmanda C Foks, Ingrid A Ran, Vanessa Frodermann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2015
Expansion of CD25+ Innate Lymphoid Cells Reduces AtherosclerosisDaniel Engelbertsen, Amanda C Foks, Noah Alberts-Grill, et al.
Vascular Pharmacology|April 19, 2023
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr<sup>-/-</sup> miceEsmeralda Hemme, Danique Biskop, Marie A C Depuydt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2017
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief ReportThomas van der Heijden, Eva Kritikou, Wouter Venema, et al.
Atherosclerosis|September 7, 2024
Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe<sup>-/-</sup> miceIlze Bot, Lucie Delfos, Esmeralda Hemme, et al.
Frontiers in Immunology|January 9, 2019
Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and AtherosclerosisJacob Amersfoort, Hidde Douna, Frank H Schaftenaar, et al.
Immunity & Ageing : I & A|May 2, 2024
Sexual dimorphism in atherosclerotic plaques of aged Ldlr<sup>-/-</sup> miceVirginia Smit, Jill de Mol, Mireia N A Bernabé Kleijn, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Plos One|November 8, 2012
Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout miceBart Lammers, Ying Zhao, Amanda C Foks, et al.
Journal of Immunological Methods|August 27, 2025
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug developmentHendrika W Grievink, Coen Breedveld, John Öhd, et al.
European Journal of Pharmacology|November 11, 2024
Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr<sup>-/-</sup> miceEsmeralda Hemme, Marie A C Depuydt, Peter J van Santbrink, et al.
Plos One|December 31, 2013
Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion developmentAmanda C Foks, Ingrid A Ran, Vanessa Frodermann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 24, 2015
Expansion of CD25+ Innate Lymphoid Cells Reduces AtherosclerosisDaniel Engelbertsen, Amanda C Foks, Noah Alberts-Grill, et al.
Vascular Pharmacology|April 19, 2023
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr<sup>-/-</sup> miceEsmeralda Hemme, Danique Biskop, Marie A C Depuydt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2017
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief ReportThomas van der Heijden, Eva Kritikou, Wouter Venema, et al.
Atherosclerosis|September 7, 2024
Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe<sup>-/-</sup> miceIlze Bot, Lucie Delfos, Esmeralda Hemme, et al.
Frontiers in Immunology|January 9, 2019
Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and AtherosclerosisJacob Amersfoort, Hidde Douna, Frank H Schaftenaar, et al.
Immunity & Ageing : I & A|May 2, 2024
Sexual dimorphism in atherosclerotic plaques of aged Ldlr<sup>-/-</sup> miceVirginia Smit, Jill de Mol, Mireia N A Bernabé Kleijn, et al.
Pageof 5